Physician profile
Todd D Williamson
NPI 1881702447
$2,966.61
in general payments reported to CMS, 2019-2025
16 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $432 · 2021: $364 · 2022: $526 · 2023: $621 · 2024: $370 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,014.82 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Allergan, INC. | $668.05 | 2019-2022 | |
| Alcon Vision LLC | $232.97 | 2022-2025 | Rocklatan, Clareon, Tryptyr |
| Ocular Therapeutix, INC. | $219.89 | 2023-2025 | Dextenza |
| Aerie Pharmaceuticals, INC. | $198.78 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $142.05 | 2019-2024 | Tecnis Iol |
| Novartis Pharmaceuticals Corporation | $99.64 | 2019-2022 | |
| Glaukos Corporation | $95.63 | 2020-2025 | Idosetr |
| Oyster Point Pharma, INC. | $80.71 | 2022-2024 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $61.19 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $48.51 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $27.40 | 2019 | |
| Bausch & Lomb Americas INC. | $22.37 | 2024 | Miebo, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $20.33 | 2025 | Xdemvy |
| Amgen INC. | $18.25 | 2025 | Tepezza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $16.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Williamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.